chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Constipation, Decreased appetite, Lethargy
Clinical narrative: Chills and uncontrollable shivering; Kept me awake; Slept most of the next day; Temperature rose to 100.5 degrees/fever; Very lethargic; No appetite; No bowel movements; Soreness at the injection site; This is a spontaneous report from a contactable consumer (patient). A 73-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9263; Expiration date was not reported) on 22Jan2021 (14:45) at a single dose on the left arm, with route of administration unspecified, for COVID-19 immunization at the public health clinic/veterans administration facility. Medical history included large B-cell lymphoma (recovered); chemotherapy from an unspecified date to Jul2020; and had a bad case of pneumonia from Oct2020 to an unspecified date. Concomitant medications included meloxicam, latanoprost and paracetamol (TYLENOL). On 23Jan2021 (01:00), the patient was very lethargic; had no appetite; and no bowel movements. On 23Jan2021 (23:45), the patient had soreness at the injection site; chills and uncontrollable shivering; was kept awake, and had slept most of the next day; and had fever/temperature rose to 100.5 degrees. The patient had received treatment for all the reported events. The outcome of the events, 'lethargic', 'no appetite', 'no bowel movements', 'soreness at the injection site', 'chills and uncontrollable shivering', 'kept awake and slept most of the next day' and 'fever', was recovered in Jan2021. The patient was not diagnosed with COVID-19 prior to vaccination, and was not tested post-vaccination.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Poor quality sleep, Pyrexia, Somnolence, Vaccination site pain
Clinical narrative: Chills and uncontrollable shivering; Kept me awake; Slept most of the next day; Temperature rose to 100.5 degrees/fever; Very lethargic; No appetite; No bowel movements; Soreness at the injection site; This is a spontaneous report from a contactable consumer (patient). A 73-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9263; Expiration date was not reported) on 22Jan2021 (14:45) at a single dose on the left arm, with route of administration unspecified, for COVID-19 immunization at the public health clinic/veterans administration facility. Medical history included large B-cell lymphoma (recovered); chemotherapy from an unspecified date to Jul2020; and had a bad case of pneumonia from Oct2020 to an unspecified date. Concomitant medications included meloxicam, latanoprost and paracetamol (TYLENOL). On 23Jan2021 (01:00), the patient was very lethargic; had no appetite; and no bowel movements. On 23Jan2021 (23:45), the patient had soreness at the injection site; chills and uncontrollable shivering; was kept awake, and had slept most of the next day; and had fever/temperature rose to 100.5 degrees. The patient had received treatment for all the reported events. The outcome of the events, 'lethargic', 'no appetite', 'no bowel movements', 'soreness at the injection site', 'chills and uncontrollable shivering', 'kept awake and slept most of the next day' and 'fever', was recovered in Jan2021. The patient was not diagnosed with COVID-19 prior to vaccination, and was not tested post-vaccination.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Labyrinthitis, Nystagmus, Polymerase chain reaction, SARS-CoV-2 test, Vertigo
Clinical narrative: severe vertigo and nystagmus; severe vertigo and nystagmus; labyrinthitis; vestibular neuritis; This is a spontaneous report from a contactable physician (reporting for himself). A 37-year-old male patient received bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date: unknown), via intramuscular route on his right arm on 16Dec2020 15:00 at single dose for covid-19 immunisation. The patient's medical history was not reported. The patient had no known allergies and had no COVID prior vaccination. There were no concomitant medications. On 24Dec2020 at 19:00 (reported as 8 days after vaccine), the patient experienced severe vertigo and nystagmus. Presumed diagnosis vestibular neuritis or labyrinthitis. It has now been one month since onset of symptoms. Much improved but still some persistent vertigo. The reporter was thinking that the events were unlikely to be due to COVID-19 vaccine but given uncertainty of etiology, he thought he should report it. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included nasal swab and polymerase chain reaction (PCR): negative on 02Jan2021. The patient had no prior vaccination. Therapeutic measures were taken as a result of onset of severe vertigo, nystagmus, "vestibular neuritis" and "labyrinthitis" which included prednisone. The outcome of the event vertigo was not recovered while recovering for the event nystagmus, "vestibular neuritis" and "labyrinthitis".  Information on the lot/batch number has been requested.; Sender's Comments: The reported events vertigo, nystagmus, vestibular neuritis, and labyrinthitis are likely intercurrent and are unrelated to suspect drug BNT162B2.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Vestibular neuronitis
Clinical narrative: severe vertigo and nystagmus; severe vertigo and nystagmus; labyrinthitis; vestibular neuritis; This is a spontaneous report from a contactable physician (reporting for himself). A 37-year-old male patient received bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date: unknown), via intramuscular route on his right arm on 16Dec2020 15:00 at single dose for covid-19 immunisation. The patient's medical history was not reported. The patient had no known allergies and had no COVID prior vaccination. There were no concomitant medications. On 24Dec2020 at 19:00 (reported as 8 days after vaccine), the patient experienced severe vertigo and nystagmus. Presumed diagnosis vestibular neuritis or labyrinthitis. It has now been one month since onset of symptoms. Much improved but still some persistent vertigo. The reporter was thinking that the events were unlikely to be due to COVID-19 vaccine but given uncertainty of etiology, he thought he should report it. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included nasal swab and polymerase chain reaction (PCR): negative on 02Jan2021. The patient had no prior vaccination. Therapeutic measures were taken as a result of onset of severe vertigo, nystagmus, "vestibular neuritis" and "labyrinthitis" which included prednisone. The outcome of the event vertigo was not recovered while recovering for the event nystagmus, "vestibular neuritis" and "labyrinthitis".  Information on the lot/batch number has been requested.; Sender's Comments: The reported events vertigo, nystagmus, vestibular neuritis, and labyrinthitis are likely intercurrent and are unrelated to suspect drug BNT162B2.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; body aches; chills; This is a spontaneous report from a non-contactable healthcare professional. A 36-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), intramuscular, left arm, on 22Jan2021 12:30 at a single dose for COVID-19 immunization. Medical history was not reported. No known allergies. Concomitant medications included multivitamins. The patient received the first dose of BNT162B2 (lot number: EK9231) on 31Dec2020, 3:30 intramuscular, right arm for COVID-19 immunization. The patient had no COVID prior to vaccination. COVID test post vaccination via nasal swab on 12Jan2021 was negative. On 23Jan2021, at 02:00, the patient experienced fever, body aches and chills. The patient did not receive any treatment for the adverse events. The patient has recovered from the events in Jan2021.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Acquired covid 19, exposed 18Jan2021. Symptoms began 22Jan2021. Positive PCR through DHEC; Acquired covid 19, exposed 18Jan2021. Symptoms began 22Jan2021. Positive PCR through DHEC; This is a spontaneous report from a contactable other healthcare professional (patient). A 42-year-old female patient (not pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK5730), via an unspecified route of administration on 05Jan2021 at 09:15 am in the Left arm at single dose for COVID-19 immunization in hospital. Medical history was not reported. Prior to vaccination, it was unknown if patient was diagnosed with COVID-19. The patient's concomitant medications included fludrocortisone acetate, loratadine, escitalopram oxalate (LEXAPRO). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient acquired COVID 19 on 22Jan2021, exposed 18Jan2021. Symptoms began 22Jan2021. Positive PCR through DHEC. Since the vaccination, patient had been tested for COVID-19 PCR on 22Jan2021: Nasal Swab, result was Positive. No treatment was received for the events. The outcome of the events was not recovered.; Sender's Comments: The positive COVID-19 test occurred 17 days after the injection of suspect vaccine BNT162B2. The lack of efficacy of suspect BNT162B2 to the COVID-19 infection cannot be totally excluded. While the steroid fludrocortisone acetate and the target disease may predispose the patient to the virus infection.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Headache, Pain in extremity
Clinical narrative: sore arm; lack of energy; Headaches on occasion.; This is a spontaneous report from a contactable consumer (patient). A 50-year-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: El1283), via an unspecified route of administration in the left arm on 18Jan2021 14:00 at a single dose for covid-19 immunization. The patient has no medical history and concomitant medications. On 19Jan2021 06:00, the patient reported sore arm, noticeable lack of energy and headaches on occasion. The patient does not have covid prior vaccination and had not tested positive post vaccination. The patient did not receive treatment for the events. The outcome of the events was not recovered.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Pruritus, Rhinorrhoea
Clinical narrative: Itchy runny nose; Itchy runny nose; cough; fatigue; headache; This is a spontaneous report from a contactable healthcare professional. A 45-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on her left arm on 23Jan2021 09:15 at a single dose for COVID-19 immunization. Medical history included Covid-19 at an unspecified date. Concomitant medication included escitalopram oxalate (LEXAPRO). The patient experienced Itchy runny nose, cough, fatigue, headache; all on 24Jan2021 07:00 AM. No treatment was received for the events. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Illness, Influenza like illness
Clinical narrative: flu-like reactions pretty sick for 3-4 days after the injection of Pfizer/BioNTech Covid-19 vaccine; flu-like reactions pretty sick for 3-4 days after the injection of Pfizer/BioNTech Covid-19 vaccine; This is a spontaneous report from a contactable consumer.  A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at single dose for COVID-19 immunisation. It was unknown if the patient was pregnant at the time of vaccination. The patient medical history and the concomitant medications were not reported.  The patient experienced flu-like reactions pretty sick for 3-4 days after the injection of pfizer/biontech covid-19 vaccine. The outcome was recovered.  It was unknown if treatment received for AE.  Information on the Lot/Batch number has been requested.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Butterfly rash, Pyrexia
Clinical narrative: malar rash; fever of 102.9/ temp of 99.7; This is a spontaneous report from a contactable nurse. A 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number and expiration date unknown, via an unspecified route of administration on 10Jan2021 at 10:30 at a single dose for COVID-19 immunization. The patient had no medical history. The patient had no other vaccine in the last four weeks or other medications in last two weeks. The patient had no known allergies. The patient's concomitant medications were not reported. The patient developed a malar rash with a fever of 102.9 for 48 hours. 6 days later the patient developed second incident of a malar rash and temp of 99.7. The events started on 10Jan2021 at 22:00. No treatment received. The patient did not recover from the events. The patient was not tested for COVID prior and post vaccination.  Information on the Lot/Batch number has been requested.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nasal congestion, SARS-CoV-2 test
Clinical narrative: Headache; Stuffy nose; chills; muscle aches; This is a spontaneous report from a contactable consumer.  A 47-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, lot/batch number not provided), via an unspecified route of administration on the left arm on 19Jan2021 13:30 at SINGLE DOSE for COVID-19 immunization at the workplace clinic. It was reported that the patient had COVID-19 on unknown date prior to vaccination. The patient's concomitant medications were not reported.  The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number not provided) on 29Dec2020 03:00 PM as COVID-19 immunization.  On 20Jan2021 02:00, the patient experienced headache, Stuffy nose, chills, and muscle aches; and recovered in 2021.  The patient was tested for COVID-19 (post vaccination) on 21Jan2021 which showed negative. It was unknown if treatment was received for the events.   Information on the Lot/Batch Number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: day 2 fever and chills; day 2 fever and chills; This is a spontaneous report from a non-contactable pharmacist. An elderly female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history was not reported. The patient was not pregnant. There were no concomitant medications. The patient experienced fever and chills on an unspecified date (also reported as day 2). No treatment was given to the patient in response to the events. It was unknown if patient had COVID prior to vaccination and the patient was not tested for COVID post vaccination. The patient recovered from the events on an unspecified date.   No follow-up attempts are possible. Information on lot/batch cannot be obtained. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasopharyngitis, Pain, Pain in extremity
Clinical narrative: sore arm; extreme cold; body aches; extreme fatigue; This is a spontaneous report from a contactable consumer (parent). A 22-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via unspecified route of administration on 21Jan2021 09:30 (lot number and expiry date unknown) at single dose for Covid-19 immunization in a workplace clinic. Medical history included Covid-19. The patient's concomitant medications were not reported. The patient had no other vaccine in four weeks. On 21Jan2021 09:30, the patient experienced sore arm and still has sore arm 3 days later, extreme cold and body aches (within 12 hour window), extreme fatigue that lasted 2 days. The patient was not Covid tested post vaccination. The outcome of the events sore arm, extreme cold, body aches, extreme fatigue was recovered in Jan2021.  Follow-up activities are possible, information on the batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Pain in extremity
Clinical narrative: feeling a metallic taste in my mouth; arm was sore yesterday more discomfort as the day went but I feel better today; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as Age: 52; Unit unspecified) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 23Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the vaccine yesterday (23Jan2021) and 1 hour into it; 30 minutes after she left the site, she started feeling a metallic taste in her mouth. The metal taste consumed her mouth and she thought it was strange. She didn't think it was anything related. Today, she was reminded of it; a little bit of the taste today (which reminded her of what she experienced yesterday) but not as overwhelming like yesterday. Her arm was sore yesterday (23Jan2021), more discomfort as the day went but she feels better today. She was thinking her arm doesn't have anything to do with her mouth, but she read the metallic taste could be a side effect, so she contacted Pfizer. It was coming from the left side of her mouth and consumed her taste buds. Wondering if that had anything to do with her fillings (she has metal filling on her left side). She feels fine. The patient also wanted to know if there was anything else, she needed to know about the second dose which was scheduled for 13Feb2021. The outcome of the event feeling a metallic taste in my mouth was unknown and recovering for the event arm was sore yesterday more discomfort as the day went but I feel better today.  Information on the lot/batch number has been requested.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes behind collar bone; This is a spontaneous report from a contactable consumer (patient). A 36-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3249), via an unspecified route of administration on 23Jan2021 13:00 at a single dose on right arm for COVID-19 immunization. The patient's medical history was not reported. The patient was not diagnosed with COVID-19 prior to vaccination. No known allergies. Concomitant medications included fish oil, ibuprofen, and niacin. The patient previously received first dose of BNT162B2 on 02Jan2021 at 1:00 PM on right arm (lot number: EK9231) for COVID-19 immunization. No other vaccines received four weeks prior to vaccination. The patient experienced swollen lymph nodes behind collar bone on 24Jan2021 18:00. It was unknown if treatment was received for the event. The patient  has not been tested for COVID-19 post vaccination. The patient was recovering from the event.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Hypersensitivity, Pharyngeal disorder, Sneezing
Clinical narrative: allergy like symptoms; Excessive sneezing; Eyes itching; Throat not closing up; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number unknown), via an unspecified route of administration in the left arm on 20Jan2021 23:30 at a single dose for COVID-19 immunization. The patient's medical history included hypertension and seasonal allergy. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Concomitant medications were not reported. It's winter and patient have self-isolated for 2 1/2 months. On22Jan2021, the patient experienced allergy like symptoms such as excessive sneezing, eyes itching, and throat not closing up. Throat not closing up and sneezing lessened with nasal spray. The patient did not receive treatment for the rest of the events. She didn't checked her temperature. Outcome of the events was not recovered.  Information about lot/batch number has been requested.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea, Neck pain, Thirst
Clinical narrative: really bad vertigo that I never had experienced before; Mild neck pain; tiredness; mild dizziness/feel like passing out; nausea; Increased thirst; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number unknown), via an unspecified route of administration in the right arm on 22Jan2021 11:30 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced mild dizziness and some nausea the afternoon of the shot (22Jan2021). Increased thirst started that evening (22Jan2021) and continued till now, regardless of how much she drink. Mild neck pain and tiredness started the next day (23Jan2021 09:30). Then on day 3 (24Jan2021), the patient woke up with really bad vertigo that she never had experienced before. If she move her head, the room spins and she get really nauseous and feel like passing out. She ended up taking motion sickness medication for these and sleeping rest of day. Outcome of the increased thirst was not recovered while of the remaining events was recovering.  Information on the lot/batch number has been requested.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: really bad vertigo that I never had experienced before; Mild neck pain; tiredness; mild dizziness/feel like passing out; nausea; Increased thirst; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number unknown), via an unspecified route of administration in the right arm on 22Jan2021 11:30 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced mild dizziness and some nausea the afternoon of the shot (22Jan2021). Increased thirst started that evening (22Jan2021) and continued till now, regardless of how much she drink. Mild neck pain and tiredness started the next day (23Jan2021 09:30). Then on day 3 (24Jan2021), the patient woke up with really bad vertigo that she never had experienced before. If she move her head, the room spins and she get really nauseous and feel like passing out. She ended up taking motion sickness medication for these and sleeping rest of day. Outcome of the increased thirst was not recovered while of the remaining events was recovering.  Information on the lot/batch number has been requested.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Body temperature, Decreased appetite, Fatigue, Feeling abnormal
Clinical narrative: Severe abdominal pain and sore abdomen; Fever at 100.2; Nausea; Fatigue; Anorexia; Foggy head; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9262, Expiration Date: May2021), via an unspecified route of administration in left arm, on 21Jan2021 at 16:15 (04:15 PM), at a single dose, for COVID-19 immunization. The patient's medical history included coronary artery disease, hypertension (HTN), diabetes, and iron supplement. The patient's concomitant medications included cilostazol and chondroitin sulfate/ collagen (INTEGRA) as iron supplement. The patient previously took sulfamethoxazole/ trimethoprim (BACTRIM) and experienced allergies. The patient was not diagnosed with COVID-19 prior to vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a hospital facility. On 22Jan2021 at 04:00 PM (around 24 hours after shot), the patient experienced severe abdominal pain and sore abdomen for 12 hours; fever at 100.2; nausea for 24 hours; and fatigue, anorexia, and foggy head for 48 hours. OTC treatment was received for the events including calcium carbonate/ famotidine/ magnesium hydroxide (PEPCID COMPLETE), calcium carbonate (TUMS), and simeticone (PHAZYME). The patient had not been tested for COVID-19 post-vaccination. The patient recovered from "Severe abdominal pain and sore abdomen" on 23Jan2021 at 04:00 AM; "Fever at 100.2" in Jan2021; from "Nausea" on 23Jan2021 at 04:00 PM (16:00); and from the remaining events on 24Jan2021 at 04:00 PM (16:00).
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Severe abdominal pain and sore abdomen; Fever at 100.2; Nausea; Fatigue; Anorexia; Foggy head; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9262, Expiration Date: May2021), via an unspecified route of administration in left arm, on 21Jan2021 at 16:15 (04:15 PM), at a single dose, for COVID-19 immunization. The patient's medical history included coronary artery disease, hypertension (HTN), diabetes, and iron supplement. The patient's concomitant medications included cilostazol and chondroitin sulfate/ collagen (INTEGRA) as iron supplement. The patient previously took sulfamethoxazole/ trimethoprim (BACTRIM) and experienced allergies. The patient was not diagnosed with COVID-19 prior to vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a hospital facility. On 22Jan2021 at 04:00 PM (around 24 hours after shot), the patient experienced severe abdominal pain and sore abdomen for 12 hours; fever at 100.2; nausea for 24 hours; and fatigue, anorexia, and foggy head for 48 hours. OTC treatment was received for the events including calcium carbonate/ famotidine/ magnesium hydroxide (PEPCID COMPLETE), calcium carbonate (TUMS), and simeticone (PHAZYME). The patient had not been tested for COVID-19 post-vaccination. The patient recovered from "Severe abdominal pain and sore abdomen" on 23Jan2021 at 04:00 AM; "Fever at 100.2" in Jan2021; from "Nausea" on 23Jan2021 at 04:00 PM (16:00); and from the remaining events on 24Jan2021 at 04:00 PM (16:00).
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Pain
Clinical narrative: severe headache along backside of head from ear to ear; Overall feeling weak, tired, and body aches; Overall feeling weak, tired, and body aches; Overall feeling weak, tired, and body aches; This is a spontaneous report from a contactable consumer (patient).  An 88-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL3248) via an unspecified route of administration in the right arm on 20Jan2021 10:30 AM at a single dose as COVID vaccine. Medical history included known allergies to crab, sulfur, penicilin. Concomitant medications (other medications in two weeks) included warfarin sodium (COUMADIN), acetylsalicylic acid (ASPIRIN LOW), lisinopril. No other vaccine in four weeks. On 21Jan2021 11:00 AM, beginning about 24 hours after injection - severe headache along backside of head from ear to ear. Overall feeling weak, tired, and body aches on 11:00 AM. Lasted about 20 hours. Treatment was not received for the events. She had no COVID prior to vaccination. She has not had COVID tested post vaccination. The outcome of the events was recovered on Jan2021.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer (patient). A 26-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 24Jan2021, at 12:00 AM at single dose (right arm) for COVID-19 immunization. The patient had no medical history. The patient was not pregnant and had no known allergies. The patient's concomitant medications were not reported. On 24Jan2021 at 12:00, the patient experienced headache. There was no therapy for the event. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient was vaccinated at a public health clinic. The patient had no Covid prior vaccination and was not Covid tested post vaccination. Outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia
Clinical narrative: Numbness to face, and left arm; headache; This is a spontaneous report from a contactable nurse (patient).  A 45-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the left arm,on 24Jan2021 11:00 at SINGLE DOSE for COVID-19 immunization.  Medical history included sulfa drug allergy, artificial heart valve (replacement) and HTN (hypertension). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Concomitant medication included warfarin sodium (COUMADIN), lisinopril and metoprolol.  The patient previously took omnicef [cefdinir] and experienced allergies.  On 24Jan2021 11:15, the patient experienced headache and numbness to face and left arm.  The outcome of events was recovering. Therapeutic measures taken as result of the events includes Benadryl.  Follow-up attempts are completed. The following information on the batch number has been requested.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Vaccination site pain, Vertigo
Clinical narrative: Muscle aches; Injection site soreness; Extreme vertigo; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 52-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL0142, expiry date: unknown), via an unspecified route of administration, in the left arm, on 18Jan2021 07:15 at a single dose for covid-19 immunization. Medical history included Meniere's disease and known allergies: shellfish. There were no concomitant medications. The patient previously took morphine and experienced known allergies: morphine, and first dose of bnt162b2 at the age of 52-year-old; lot number: EL1284 on 27Dec2020 0700, in the left arm for covid-19 immunization. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient was not diagnosed with covid-19 prior to vaccination and was not tested for covid-19 post vaccination. On 23Jan2021 0500, the patient experienced muscle aches, injection site soreness, extreme vertigo and nausea. All the events resulted in emergency room (ER) visit. Therapeutic measures were taken for all the events which included diphenhydramine (BENADRYL)and prochlorperazine (COMPAZINE). Outcome of all the events was recovered on unspecified date in Jan2021.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia
Clinical narrative: Progressive muscle aches, deep - in left arm (arm of injection), bilateral legs, and low back; fatigue; Chills; This is a spontaneous report from a contactable nurse (patient). A 30-year-old female patient received the first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Lot number: Unknown), via an unspecified route of administration in the left arm on 22Jan2021 10:15 at a single dose for COVID-19 immunization. The vaccine was given in a hospital. Medical history included IBS (irritable bowel syndrome) and known allergies: Sulfa. The patient was not pregnant at the time of vaccination. The patient had no COVID prior to vaccination. The patient had not been tested for COVID post vaccination. The patient has not received any vaccine in 4 weeks. Concomitant medication included macrogol 3350 (MIRALAX), Olly prenatal gummies and unspecified blood builder. On 23Jan2021 at 2pm, the patient experienced progressive muscle aches, deep - in left arm (arm of injection), bilateral legs, and low back. Also chills and fatigue. There was no treatment given for the events. The outcome of the events was recovering.   Information on the Lot/Batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Cough, Feeling cold
Clinical narrative: cough; felt cold; soreness in shoulders and back; soreness in shoulders and back; This is a spontaneous report from a contactable consumer via medical information team. A female patient of an unspecified age (reported as 78, no unit) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history included asthma. The patient had no concomitant medications. The patient took the first shot and she picked up a cough. The patient had a cough anyway because of asthma but seemed to have picked up an extra one. The patient felt cold most of the time. She has soreness in shoulders and back and would receive the second dose in February. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Movement disorder, Pyrexia, Vaccination site swelling
Clinical narrative: Swollen lymph nodes on Left underarm; Painful to move; Swelling at injection site; Low grade fever; fatigue; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL9263) via an unspecified route of administration on the left arm on 22Jan2021 16:30 at a single dose for COVID-19 immunization. Medical history included known allergies: Sulfa. Concomitant medication included atomoxetine hydrochloride (STRATTERA) and bupropion hydrochloride (WELLBUTRIN). On 23Jan2021 02:30 AM, the patient experienced swollen lymph nodes on Left underarm. Painful to move. Swelling at injection site. Low grade fever and fatigue day 2 and 3. No treatment was received for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovering.
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chills; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced chills on an unspecified date. Outcome of event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Eye oedema
Clinical narrative: Eye puffiness; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on 09Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced eye puffiness on an unspecified date. It was further reported that the patient started using a facial cream around the same time and developed eye puffiness. She discontinued the cream but her eyes are still puffy. The outcome of the event was unknown.  Information on Lot/Batch has been requested.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Chest pain; This is a spontaneous report from a contactable nurse. A 22-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number and expiration date unknown, via an unspecified route of administration on 22Jan2021 08:30 at single dose on right arm for COVID-19 immunization. The patient is not pregnant. The patient had no medical history and no known allergies. The patient had no other vaccine in four weeks. The patient had other medications in the last two weeks. Concomitant medication was unspecified. The patient experienced chest pain on 23Jan2021 13:00. The patient had no treatment and did not recover from the event. The patient was not tested for COVID prior and post vaccination.  Information on the lot/batch number has been requested.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, SARS-CoV-2 test
Clinical narrative: Temperatures from 99.5 to 103. Higher temps in first 6 to 7 days/marks 13 days with temps typically ranging from 99.5 to 101.7. Temps above 100 majority of the day; This is a spontaneous report from a contactable nurse (patient herself). A non-pregnant 30-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), second dose (lot number: EK9231) at age 30 years, via an unspecified route of administration on the left arm, on 12Jan2021, at single dose, for COVID-19 vaccination. The patient medical history included having first dose of Pfizer-BioNTech COVID-19 mRNA vaccine (lot number: EL0140) on 23Dec2020 at 07:15 AM intramuscular on the left arm. Patient had no known allergies. Patient have not had COVID before. Concomitant medication included garlic (allium sativum), ashwagandha, astaxanthin, curcuma longa (TURMERIC), fish oil, minerals nos, vitamins nos (CALCIUM PLUS), panax ginseng (AMERICAN GINSENG), ubidecarenone (COQ10), vitamin b complex and multivitamins (all from care/of supplement company). Patient had not had any other vaccine in four weeks. On 12Jan2021 21:00, the patient experienced temperatures (briefly and very intermittently normal) ranging from 99.5 to 103. Higher temps in the first 6 to 7 days. At the time of report, marks 13 days with temps typically ranging from 99.5 to 101.7. Temps above 100 majority of the day. The patient also underwent lab tests and procedures which included PCR saliva test on 18Jan2021 and 22Jan2021 with negative results. Facility type vaccine: Hospital. Adverse event resulted in doctor or other healthcare professional office or clinic visit. It was unknown if treatment was given for the event. The outcome of the event was not recovered.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Headache, Heart rate, Neurological symptom, Paraesthesia oral
Clinical narrative: wave of neurological effects app 5-6 inches wide in a swath starting at back of neck and proceeding up over top of head & down my face to my chin; tingling lips; minor headache; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL8982, expiry date: unknown), via an unspecified route of administration, in the right arm, on 24Jan2021 10:45 at a single dose for covid-19 immunization. Medical history included occipital neuralgia, migraines, and known allergies: chlorine, latex. The patient's concomitant medications were not reported. The patient previously took erythromycin and experienced allergy. The patient is not pregnant. The patient has not had any vaccine in four weeks and no other medications in two weeks. The patient was not diagnosed with covid-19 prior to vaccination and was not tested for covid-19 post vaccination. On 24Jan2021 15:00, the patient experienced "a wave of neurological effects app 5-6 inches wide in a swath starting at back of neck and proceeding up over top of head and down my face to my chin. It included tingling lips and minor headache." The patient had no change in blood pressure (BP), heart rate or respirations. No flush or sensation of heat-almost a sensation of numbness. The patient did not receive any treatment for all the events. Outcome of all the events was recovering.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory rate
Clinical narrative: wave of neurological effects app 5-6 inches wide in a swath starting at back of neck and proceeding up over top of head & down my face to my chin; tingling lips; minor headache; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL8982, expiry date: unknown), via an unspecified route of administration, in the right arm, on 24Jan2021 10:45 at a single dose for covid-19 immunization. Medical history included occipital neuralgia, migraines, and known allergies: chlorine, latex. The patient's concomitant medications were not reported. The patient previously took erythromycin and experienced allergy. The patient is not pregnant. The patient has not had any vaccine in four weeks and no other medications in two weeks. The patient was not diagnosed with covid-19 prior to vaccination and was not tested for covid-19 post vaccination. On 24Jan2021 15:00, the patient experienced "a wave of neurological effects app 5-6 inches wide in a swath starting at back of neck and proceeding up over top of head and down my face to my chin. It included tingling lips and minor headache." The patient had no change in blood pressure (BP), heart rate or respirations. No flush or sensation of heat-almost a sensation of numbness. The patient did not receive any treatment for all the events. Outcome of all the events was recovering.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Very swollen lymph nodes; This is a spontaneous report from a contactable nurse (patient herself). A 34-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration (left arm), on 20Jan2021 11:30, at single dose, for covid-19 immunization. Medical history included hypothyroid, insulin resistant, and tachycardia. The patient has no known allergies. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), on 30Dec2020 19:00, vaccine location left arm, for covid-19 immunization at 34-years-old. The patient experienced very swollen lymph nodes on 21Jan2021 06:00 AM. The patient had not recovered from the event. It was unknown if treatment was received for the event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination and have not been COVID tested post vaccination.  Information about the lot/batch number has been requested.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Very swollen lymph nodes; This is a spontaneous report from a contactable nurse (patient herself). A 34-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration (left arm), on 20Jan2021 11:30, at single dose, for covid-19 immunization. Medical history included hypothyroid, insulin resistant, and tachycardia. The patient has no known allergies. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), on 30Dec2020 19:00, vaccine location left arm, for covid-19 immunization at 34-years-old. The patient experienced very swollen lymph nodes on 21Jan2021 06:00 AM. The patient had not recovered from the event. It was unknown if treatment was received for the event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination and have not been COVID tested post vaccination.  Information about the lot/batch number has been requested.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Fatigue, Lymphadenopathy, Musculoskeletal chest pain, Oropharyngeal pain
Clinical narrative: extreme fatigue; Extremely painful to the touch on bones/ribs around left breast thinking swollen lymph nodes. Same side as injection site/ left arm; Extremely painful to the touch on bones/ribs around left breast thinking swollen lymph nodes. Same side as injection site/ left arm; Extremely painful to the touch on bones/ribs around left breast thinking swollen lymph nodes. Same side as injection site/ left arm; Sore throat; This is a spontaneous report from a contactable other healthcare professional (patient). A 33-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on the left arm on 20Jan2021 15:30 at a single dose for COVID-19 immunization. Medical history included asthma, anxiety, depression; known allergies: sulfa and pineapple, bananas. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), levothyroxine, tramadol, paracetamol (TYLENOL) and alprazolam (XANAX). On 23Jan2021 11:00 AM, the patient experienced extremely painful to the touch on bones/ribs around left breast thinking swollen lymph nodes. Same side as injection site/ left arm. Sore throat only a day. Day 5- extreme fatigue. No treatment was received for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. Outcome of the event sore throat was recovered on 24Jan2021, while recovering for the other events.    Information on the lot/batch number has been requested.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Rash pruritic, Skin burning sensation
Clinical narrative: Red splotchy rash on left and right upper flank areas; itching and burning associated with rash; itching and burning associated with rash; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient).  A 29-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL3246) intramuscular in the left arm, at the age of 28-years, on 21Jan2021 15:30 (03:30 PM) at a single dose as Covid vaccine. Medical history included cyclic vomiting syndrome.  There were no concomitant medications (no other vaccine in four weeks and no other medications in two weeks). The patient had known medication allergies including diphenhydramine hydrochloride (BENADRYL), propranolol hydrochloride (INDERAL), sumatriptan succinate (IMITREX), metoclopramide (REGLAN), and benzatropine mesilate (COGENTIN). The patient experienced red splotchy rash on left and right upper flank areas, itching and burning associated with rash on 23Jan2021. Treatment was not received for the events. She had no Covid prior to vaccination. She has not had Covid tested post vaccination. The outcome of the events was not recovered.